Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,713 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases.
Park SK, Choi CH, Chun J, Lee H, Kim ES, Park JJ, Park CH, Lee BI, Jung Y, Park DI, Kim DY, Park H, Jeen YT; IBD Research Group of the Korean Association for the Study of Intestinal Diseases. Park SK, et al. Among authors: choi ch. Intest Res. 2020 Jan;18(1):18-33. doi: 10.5217/ir.2019.09155. Epub 2020 Jan 30. Intest Res. 2020. PMID: 32013312 Free PMC article. Review.
Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease.
Kim BJ, Choi YS, Jang BI, Park YS, Kim WH, Kim YS, Jung SA, Han DS, Kim JS, Choi JH, Choi CH, Jeen YT, Cheon JH, Ye BD, Yang SK, Kim YH. Kim BJ, et al. Among authors: choi jh, choi ys, choi ch. Inflamm Bowel Dis. 2011 Jun;17(6):1308-13. doi: 10.1002/ibd.21490. Epub 2010 Nov 4. Inflamm Bowel Dis. 2011. PMID: 21053248
Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
Kim YS, Kim YH, Kim WH, Kim JS, Park YS, Yang SK, Ye BD, Jang BI, Jung SA, Jeen YT, Cheon JH, Choi YS, Choi JH, Kim BJ, Choi CH, Han DS. Kim YS, et al. Among authors: choi jh, choi ys, choi ch. Clin Chim Acta. 2011 Aug 17;412(17-18):1527-32. doi: 10.1016/j.cca.2011.04.029. Epub 2011 May 6. Clin Chim Acta. 2011. PMID: 21575618
[Guidelines for the management of ulcerative colitis].
Choi CH, Kim YH, Kim YS, Ye BD, Lee KM, Lee BI, Jung SA, Kim WH, Lee H; IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Choi CH, et al. Korean J Gastroenterol. 2012 Feb;59(2):118-40. doi: 10.4166/kjg.2012.59.2.118. Korean J Gastroenterol. 2012. PMID: 22387836 Free article. Korean.
[Guidelines for the management of Crohn's disease].
Ye BD, Yang SK, Shin SJ, Lee KM, Jang BI, Cheon JH, Choi CH, Kim YH, Lee H; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Ye BD, et al. Among authors: choi ch. Korean J Gastroenterol. 2012 Feb;59(2):141-79. doi: 10.4166/kjg.2012.59.2.141. Korean J Gastroenterol. 2012. PMID: 22387837 Free article. Korean.
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective study.
Lee KM, Jeen YT, Cho JY, Lee CK, Koo JS, Park DI, Im JP, Park SJ, Kim YS, Kim TO, Lee SH, Jang BI, Kim JW, Park YS, Kim ES, Choi CH, Kim HJ; IBD study Group of Korean Association for the Study of Intestinal Diseases. Lee KM, et al. Among authors: choi ch. J Gastroenterol Hepatol. 2013 Dec;28(12):1829-33. doi: 10.1111/jgh.12324. J Gastroenterol Hepatol. 2013. PMID: 23829336
1,713 results